The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction-Reference-Cited by-同舟云学术

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction

Published:2015-06 Issue:6 Volume:3 Page:429-441
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Carson Peter E.,Anand Inder S.,Win Sithu,Rector Thomas,Haass Markus,Lopez-Sendon Jose,Miller Alan,Teerlink John R.,White Michel,McKelvie Robert S.,Komajda Michel,Zile Michael R.,McMurray John J.,Massie Barry

Funder

Bristol-Myers Squibb

Minneapolis Veterans Affairs Health Care System

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort;Vasan;J Am Coll Cardiol,1999

2. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis;Hogg;J Am Coll Cardiol,2004

3. Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease;Packer;Circ Heart Fail,2011

4. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial;Ahmed;Circulation,2006

5. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial;Yusuf;Lancet,2003

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real world experience in effect of torsemide vs. furosemide after discharge in patients with HFpEF;ESC Heart Failure;2024-09-05

2. The Effect of Recurrent Heart Failure Hospitalizations on the Risk of Cardiovascular and all-Cause Mortality: a Systematic Review and Meta-Analysis;Current Cardiology Reports;2024-09-04

3. Rates and predictors of cardiovascular and non‐cardiovascular outcomes in heart failure with preserved ejection fraction;ESC Heart Failure;2024-07-29

4. Insulin Resistance/Hyperinsulinemia, Neglected Risk Factor for the Development and Worsening of Heart Failure with Preserved Ejection Fraction;Biomedicines;2024-04-04

5. Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): A systematic review and meta-analysis;Current Problems in Cardiology;2024-03